Mereo BioPharma Group plc (MREO) › RevenueMereo BioPharma Group plc (MREO) — RevenueAnnual figures by period end, from SEC filings.2022-12-31: $02023-12-31: $10.00M2024-12-31: $02025-12-31: $500.0K$500.0K2022-12-31Revenue (USD)2025-12-31Period endedRevenueChange YoYSource filing2025-12-31$500.0K—2026-03-19From 2025-01-012024-12-31$0-100.0%2026-03-19From 2024-01-012023-12-31$10.00M—2025-03-26From 2023-01-012022-12-31$0—2024-03-27From 2022-01-01Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)